Appili Therapeutics Inc.
Appili Therapeutics Inc. (APLI.TO) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · APLI.TO · as of Jun 9, 2026
Key Statistics
Explore Appili Therapeutics Inc. Data
apli.to stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
apli.to competitorsAPLI.TO
AGN.CN
APS.TO
CDVA.CN
HEAL.CN
KNE.VStock Performance
Full HistoryAbout Appili Therapeutics Inc.
Appili Therapeutics Inc. a Canadian biopharmaceutical firm headquartered in Halifax and founded in 2015, specializes in sourcing and advancing innovative treatments to address critical gaps in infect…
what is appili therapeutics inc. · apli.to stock overview · appili therapeutics inc. company profile · who is appili therapeutics inc. ceo · apli.to TSX · appili therapeutics inc. headquarters · appili therapeutics inc. business segments
About Stock Overview & Key Data
Appili Therapeutics Inc. (APLI.TO) is a Healthcare company in the Biotechnology industry, listed on TSX since Jun 25, 2019. As of the latest trading session, APLI.TO stock price is $0.01, with a market capitalization of $1.9M. The stock has returned +0.00% over the past 12 months and -40.00% year-to-date.
In fiscal year 2025, Appili Therapeutics Inc. reported revenue of $100443.00. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Appili Therapeutics Inc. (APLI.TO) stock price is $0.01. The stock is traded on TSX under the ticker symbol APLI.TO. The 52-week range is $0.01 – $0.04.